Search Results for 'corevalve'
-
Cardiovascular
Getting to the Heart of the Matter: An Examination of Transcatheter Heart Technologies
Transcatheter structural heart therapies stand to replace their open-heart counterparts thanks to technological innovations and expanded patient access.Sam Brusco, Associate Editor 03.04.20
-
415 CAPITAL Closes New Medtech Venture Capital Fund
The fund will invest in medical device companies in Europe, Israel and the United States.Business Wire 02.25.20
-
Cardiovascular | Surgical
Admedus Turns Focus to TAVR Market
The company sold its CardioCel and VascuCel business to LeMaitre Vascular for up to $24.9MGlobalData 10.23.19
-
Cardiovascular
The TAVR Plot Thickens
Transcatheter aortic valve replacement (TAVR) surgery has typically targeted patients considered too risky to undergo open-heart surgery.Sam Brusco, Associate Editor 09.06.19
-
Cardiovascular
Medtronic Evolut TAVR System Gains Approval for Expanded Indications
System approved for low risk patients.Medtronic plc 08.19.19
-
-
Study Predicts 67 Percent Growth for the $2.7 Billion European Cardiac Surgery Market
TAVI and TMVr adoption expected to fuel the increase by 2024.Business Wire 07.16.19
-
CardioMech Expands Mitral Leadership Team
Company elects new directors, board advisor, and appoints vice president of Finance on the heels of a $2.5 million financing.Business Wire 04.30.19
-
Tubing & Extrusion
Extrapolating Extrusion
A roundtable discussion of the myriad trends and challenges affecting extruders for the medical device industry.Sam Brusco, Associate Editor 10.16.18
-
-
ReCor Medical Sold to Otsuka Holdings
Created in 2009 by Sofinnova Partners, the firm specializes in the treatment of hypertension.Business Wire 07.10.18
-
Cardiovascular
Medtronic Study to Evaluate the CoreValve Evolut PRO System in 'Everyday' Clinical Practice
Study designed to assess longer-term clinical performance of next-generation Evolut PRO TAVI System.Medtronic plc 09.22.17
-
Cardiovascular
CE Mark, Launch of Medtronic’s CoreValve Evolut PRO Transcatheter Valve
Device is indicated for the treatment of severe aortic stenosis for symptomatic patients.Medtronic plc 07.31.17
-
-
Cardiovascular
Medtronic’s TAVR Access Expanded with FDA Approval
Self-expanding CoreValve Evolut TAVR Platform helps address needs of intermediate-risk patients.Medtronic plc 07.11.17
-
Cardiovascular | Surgical
FDA Approves Medtronic's Transcatheter Valve with Advanced Sealing
Self-expanding, recapturable heart valve demonstrates high survival, low stroke, and minimal paravalvular leak.Medtronic 03.22.17
-
Contract Manufacturing | Testing
-
Cardiovascular | Contract Manufacturing | Materials | Molding | R&D & Design | Software & IT | Tubing & Extrusion
Preferred Circulation
The advancement of minimally invasive technologies is fueling growth of the global interventional medical device market.Michael Barbella, Managing Editor 09.08.16
-
R&D & Design
Medtronic’s CoreValve Evolut R System Receives CE Mark
Next-generation recapturable device is the first-of-its-kind approved in Europe to treat intermediate risk patients.Medtronic 08.02.16
-
Cardiovascular | Contract Manufacturing
-
Cardiovascular
NeoChord Appoints VP of European Commercial Sales
Company also achieves milestone of more than 400 patients treated with the DS1000 System.Business Wire 05.10.16
-
Cardiovascular | R&D & Design
Positive Data Reported from Medtronic’s Corevalve High Risk Study
Study continues to show TAVR is superior to surgery for combined endpoint of mortality and stroke.Medtronic plc 04.04.16
-
Cardiovascular
First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Trial
Trial subjects enrolled in Harrisburg, Pa.Medtronic plc 04.01.16
-
4Tech Appoints Global VP of Therapy Development
New hire has 10 years of experience working with transcatheter valves.4Tech Inc. 03.17.16
-
Cardiovascular
Medtronic Enrolls First Patients in Corevalve Clinical Study
Study to evaluate the Corevalve Evolut R system in “real world” settingMedtronic plc 03.07.16
-
Cardiovascular | Contract Manufacturing | R&D & Design
-
Cardiovascular | R&D & Design
-
R&D & Design
FDA Approves Expanded Indication for Medtronic's CoreValve
Original FDA approval came last year.04.01.15
-
Cardiovascular | R&D & Design
Medtronic Earns Japanese OK for CoreValve System
Approval based on data from U.S. pivotal trials.03.30.15
-
Cardiovascular
Medtronic CoreValve TAVR Device Better Than Surgery, Two-Year Study Finds
Study findings released during annual meeting of the American College of Cardiology.03.16.15
-
R&D & Design
First Implants Completed in Medtronic Corevalve Trial
The self-expanding valve was recently granted CE mark approval, but is investigational stateside.09.10.14
-
R&D & Design
Medtronic Earns CE Mark for CoreValve Evolut R System
The 23 mm valve provides recapture and repositioning options during deployment.09.04.14
-
R&D & Design
Meta-Analysis Finds 2.5-Fold Higher Pacemaker Risk With CoreValve
Predictors may help physicians avoid atrioventricular block-related complications, research indicates.07.16.14
-
R&D & Design
FDA OKs Expanded Indication for Medtronic's CoreValve TAVR Device
Company now can be used for a broader category of patients.06.18.14
-
R&D & Design
New Clinical Data Supports Clinical Efficacy of Medtronic's CoreValve
Latest round of data examines non-traditional access routes for implanting the heart valve replacement device.04.30.14
-
Cardiovascular | R&D & Design
FDA Approves Medtronic's CoreValve Technology
Agency's approval comes on the heels of a protracted legal battle over the technology with Edwards Lifesciences.01.17.14
-
Court Allows Medtronic to Resume Marketing of Corevalve in Germany
Company previously had been ordered to cease in light of perceived infringed patent held by Edwards Lifesciences.11.15.13
-
Cardiovascular
-
Cardiovascular
Medtronic Unveils Impressive U.S. CoreValve Trial Data
Based on trial results, the FDA will waive advisory panel review for first CoreValve approval indication.10.30.13
-
Former CoreValve President Accepts Job at CardiAQ Valve Rob Michiels has joined another heart val
...02.07.11
-
Former CoreValve CEO to Join White Pine Medical
Medical device fund to start out with $50 million.Editor 02.09.10
-
Former CoreValve CEO to Join White Pine Medical
Medical device fund to start out with $50 million.Editor 02.09.10
-
CoreValve Wins Patent Infringement Lawsuit Against Edwards Lifesciences
Ruling allows company to continue expanded evaluationEditor 10.27.08
-
CoreValve Wins Patent Infringement Lawsuit Against Edwards Lifesciences
Ruling allows company to continue expanded evaluationEditor 10.27.08
